BTKi stands for Bruton tyrosine kinase (BROO-tuhn TY-ruh-seen KYnays) inhibitor. CALQUENCE (acalabrutinib) is a BTKi—a targeted therapy that helps stop the growth and survival of B cells that become cancerous.